Recovery from opiate addiction is not an easy path. For those attempting to stop, withdrawal symptoms can feel like a full-body rebellion; nausea and muscle aches, chills, anxiety, insomnia, and mood ...
Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results